Virios Therapeutics News

Virios Therapeutics | 424B4: Prospectus

May 20 16:14 ET

Virios Therapeutics | 8-K: Current report

May 20 09:30 ET

Virios Therapeutics | 424B4: Prospectus

May 17 16:04 ET

Virios Therapeutics | 10-Q: Quarterly report

May 10 10:34 ET

Virios Therapeutics | 8-K: Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 9 08:02 ET

Virios Therapeutics | 8-K: Current report

May 7 17:31 ET

Virios Therapeutics | ARS: Annual Report to Security Holders

Apr 29 17:31 ET

Virios Therapeutics | DEF 14A: Definitive information statements

Apr 25 16:36 ET

Virios Therapeutics | 10-K/A: Annual report (Amendment)

Mar 8 17:02 ET

Virios Therapeutics | 8-K: Current report

Mar 6 16:37 ET

Virios Therapeutics | 10-K: Annual report

Mar 1 09:14 ET

Virios Therapeutics | 8-K: Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 29 09:28 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pridgen William

Feb 28 13:23 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thomas John C

Feb 28 13:13 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Whitley Richard James

Feb 28 13:08 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keefer David R

Feb 28 13:03 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burch Richard Alan

Feb 28 12:58 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director De La Rosa Abel

Feb 28 12:58 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walsh Angela

Feb 28 12:53 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grosswald Ralph

Feb 28 12:53 ET